334 related articles for article (PubMed ID: 26483409)
1. The A1 Subunit of Shiga Toxin 2 Has Higher Affinity for Ribosomes and Higher Catalytic Activity than the A1 Subunit of Shiga Toxin 1.
Basu D; Li XP; Kahn JN; May KL; Kahn PC; Tumer NE
Infect Immun; 2016 Jan; 84(1):149-61. PubMed ID: 26483409
[TBL] [Abstract][Full Text] [Related]
2. Conserved Arginines at the P-Protein Stalk Binding Site and the Active Site Are Critical for Ribosome Interactions of Shiga Toxins but Do Not Contribute to Differences in the Affinity of the A1 Subunits for the Ribosome.
Basu D; Kahn JN; Li XP; Tumer NE
Infect Immun; 2016 Dec; 84(12):3290-3301. PubMed ID: 27600507
[TBL] [Abstract][Full Text] [Related]
3. Differences in Ribosome Binding and Sarcin/Ricin Loop Depurination by Shiga and Ricin Holotoxins.
Li XP; Tumer NE
Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28398250
[TBL] [Abstract][Full Text] [Related]
4. Do the A subunits contribute to the differences in the toxicity of Shiga toxin 1 and Shiga toxin 2?
Basu D; Tumer NE
Toxins (Basel); 2015 Apr; 7(5):1467-85. PubMed ID: 25938272
[TBL] [Abstract][Full Text] [Related]
5. Shiga toxin 1 is more dependent on the P proteins of the ribosomal stalk for depurination activity than Shiga toxin 2.
Chiou JC; Li XP; Remacha M; Ballesta JP; Tumer NE
Int J Biochem Cell Biol; 2011 Dec; 43(12):1792-801. PubMed ID: 21907821
[TBL] [Abstract][Full Text] [Related]
6. AB5 Preassembly Is Not Required for Shiga Toxin Activity.
Pellino CA; Karve SS; Pradhan S; Weiss AA
J Bacteriol; 2016 Jun; 198(11):1621-1630. PubMed ID: 27002129
[TBL] [Abstract][Full Text] [Related]
7. Identification of amino acids critical for the cytotoxicity of Shiga toxin 1 and 2 in Saccharomyces cerevisiae.
Di R; Kyu E; Shete V; Saidasan H; Kahn PC; Tumer NE
Toxicon; 2011 Mar; 57(4):525-39. PubMed ID: 21184769
[TBL] [Abstract][Full Text] [Related]
8. Structure-Function Analysis of the A1 Subunit of Shiga Toxin 2 with Peptides That Target the P-Stalk Binding Site and Inhibit Activity.
Li XP; Rudolph MJ; Chen Y; Tumer NE
Biochemistry; 2024 Apr; 63(7):893-905. PubMed ID: 38467020
[TBL] [Abstract][Full Text] [Related]
9. A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.
Tremblay JM; Mukherjee J; Leysath CE; Debatis M; Ofori K; Baldwin K; Boucher C; Peters R; Beamer G; Sheoran A; Bedenice D; Tzipori S; Shoemaker CB
Infect Immun; 2013 Dec; 81(12):4592-603. PubMed ID: 24082082
[TBL] [Abstract][Full Text] [Related]
10. Shiga Toxin Type 1a (Stx1a) Reduces the Toxicity of the More Potent Stx2a
Petro CD; Trojnar E; Sinclair J; Liu ZM; Smith M; O'Brien AD; Melton-Celsa A
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670557
[TBL] [Abstract][Full Text] [Related]
11. Bimodal Response to Shiga Toxin 2 Subtypes Results from Relatively Weak Binding to the Target Cell.
Cherubin P; Fidler D; Quiñones B; Teter K
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31527121
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for the interaction of Shiga toxin 2a with a C-terminal peptide of ribosomal P stalk proteins.
Rudolph MJ; Davis SA; Tumer NE; Li XP
J Biol Chem; 2020 Nov; 295(46):15588-15596. PubMed ID: 32878986
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives.
Henrique IM; Sacerdoti F; Ferreira RL; Henrique C; Amaral MM; Piazza RMF; Luz D
Front Cell Infect Microbiol; 2022; 12():825856. PubMed ID: 35223548
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Shiga Toxin 1, 2 and Their Subunits on Cytokine and Chemokine Expression by Human Macrophage-Like THP-1 Cells.
Brandelli JR; Griener TP; Laing A; Mulvey G; Armstrong GD
Toxins (Basel); 2015 Oct; 7(10):4054-66. PubMed ID: 26473922
[TBL] [Abstract][Full Text] [Related]
15. Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome.
Karpman D; Papadopoulou D; Nilsson K; Sjögren AC; Mikaelsson C; Lethagen S
Blood; 2001 May; 97(10):3100-8. PubMed ID: 11342436
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli.
Luz D; Chen G; Maranhão AQ; Rocha LB; Sidhu S; Piazza RM
PLoS One; 2015; 10(3):e0120481. PubMed ID: 25790467
[TBL] [Abstract][Full Text] [Related]
17. Activation of the Classical Mitogen-Activated Protein Kinases Is Part of the Shiga Toxin-Induced Ribotoxic Stress Response and May Contribute to Shiga Toxin-Induced Inflammation.
Jandhyala DM; Ahluwalia A; Schimmel JJ; Rogers AB; Leong JM; Thorpe CM
Infect Immun; 2016 Jan; 84(1):138-48. PubMed ID: 26483408
[TBL] [Abstract][Full Text] [Related]
18. Method for the Detection of the Cleaved Form of Shiga Toxin 2a Added to Normal Human Serum.
Rocchetti L; Munari B; Varrone E; Porcellini E; Orth-Höller D; Würzner R; Carnicelli D; Brigotti M
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33530614
[TBL] [Abstract][Full Text] [Related]
19. Development and Evaluation of a Novel VHH-Based Immunocapture Assay for High-Sensitivity Detection of Shiga Toxin Type 2 (Stx2) in Stool Samples.
Melli LJ; Zylberman V; Hiriart Y; Lauche CE; Baschkier A; Pardo R; Miliwebsky E; Chinen I; Rivas M; Goldbaum FA; Ugalde JE; Comerci DJ; Ciocchini AE
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31826960
[TBL] [Abstract][Full Text] [Related]
20. A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.
Selyunin AS; Mukhopadhyay S
Traffic; 2015 Dec; 16(12):1270-87. PubMed ID: 26420131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
